Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
Archives of Dermatological Research|April 19, 2003
Downregulation of tapasin expression in progressive human malignant melanomaJ Dissemond, T Kothen, J Mörs, et al.
Cell Death & Disease|March 11, 2016
Overcoming MITF-conferred drug resistance through dual AURKA/MAPK targeting in human melanoma cellsG Pathria, B Garg, V Borgdorff, et al.
The Journal of Pathology|May 1, 1996
Type-1 plasminogen activator inhibitor in human renal cell carcinomaS N Wagner, M J Atkinson, S Thanner, et al.
Vox Sanguinis|December 22, 2006
Apheresis products of the Amicus and the AS.TEC 204 cell separators are comparable with regard to dendritic cells derived from the mononuclear cell collectionG C Leitner, F Koszik, T Rudnicki, et al.
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|September 1, 1992
Expression of stromelysin 3 in the stromal elements of human basal cell carcinomaS N Wagner, C Ruhri, K Kunth, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|May 30, 1998
Immune response against human primary malignant melanoma: a distinct cytokine mRNA profile associated with spontaneous regressionS N Wagner, T Schultewolter, C Wagner, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|April 1, 1996
Inhibition of T cell cAMP formation by cyclosporin A and FK506H M Ockenfels, S N Wagner, P Oeljeklaus, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 6, 1995
Priming of tumor-specific T cells in the draining lymph nodes after immunization with interleukin 2-secreting tumor cells: three consecutive stages may be required for successful tumor vaccinationG Maass, W Schmidt, M Berger, et al.
The American Journal of Pathology|July 1, 1995
Modulation of urokinase and urokinase receptor gene expression in human renal cell carcinomaS N Wagner, M J Atkinson, S Thanner, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Pathologie|January 1, 1994
Genetic modification of cells by receptor-mediated adenovirus-augmented gene delivery: a new approach for immunotherapy of cancerK Zatloukal, A Schneeberger, M Berger, et al.
Pageof 6